GlassScriptPhysician profile
Scott J Harris
NPI 1942273099
$1,900.92
in general payments reported to CMS, 2019-2025
16 companies · $1,425 in 2025
The $1,425 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.55 · 2023: $26.00 · 2024: $433 · 2025: $1,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,884.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $525.62 | 2022-2025 | |
| Ucb, INC. | $294.51 | 2024-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $199.64 | 2024-2025 | Tremfya, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $185.56 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $148.72 | 2024-2025 | Purified Cortrophin Gel |
| Organon LLC | $117.06 | 2025 | Hadlima, Renflexis |
| Amgen INC. | $101.00 | 2024-2025 | Otezla, Otezla, Krystexxa |
| Pfizer INC. | $70.23 | 2024-2025 | |
| Glaxosmithkline, LLC. | $69.69 | 2024-2025 | Benlysta, Nucala |
| Mallinckrodt Hospital Products INC. | $50.28 | 2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $41.54 | 2024 | |
| Horizon Therapeutics Plc | $26.00 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $21.62 | 2024 | Orencia |
| Kiniksa Pharmaceuticals International, Plc | $18.96 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.97 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $14.52 | 2025 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.